ABL1 and cancer: For example, the anti-cancer drug imatinib crystallizes in complex with an inactive conformation of the Abl kinase, known as the ‘DFG—out’ conformation [48], while other ligands, such as dasatinib, are bound to the active ‘DFG—in’ conformation of Abl [49].